COO · Transaction Jun 5, 2026 · Filed Jul 2, 2026 · $1,001 to $15,000
XNAS · COO
+0.20% · +$0.1500 · Vol 1.5M
After hours · updated 16:31:56 ET
The Cooper Companies, Inc. Common Stock
OPHTHALMIC GOODS
$74.84
Veridion Score
BETAMEDIUM CONF · 5/6 factorsStale score · Tue Aug 4 · completed session · 23h old · Scheduled each trading day · Markets closed · resumes Thu 9:30 ET · COO
MethodologyCOO
The Cooper Companies, Inc. Common Stock
Stale score · Tue Aug 4 · completed session · 23h old · Scheduled each trading day · Markets closed · resumes Thu 9:30 ET
BUY BIAS
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
69/ 100
Veridion Score
BUY BIAS · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Stale score · Tue Aug 4 · completed session · 23h old · Scheduled each trading day · Markets closed · resumes Thu 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is COO moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About The Cooper Companies, Inc. Common Stock
OPHTHALMIC GOODSFounded
1990
Listed
1983
Employees
15K
Country
US
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$74.75
Day high
$75.02
Day low
$73.82
Previous close
$74.69
52W high
$84.32
-11.24% from high
52W low
$58.98
63% of range
Market cap
$14.6B
P/E
62.89×
EPS
$1.19
Beta
0.07
Shares out
195M
Volume
1.5M
0.62× rel vol
Avg volume
2.4M
VWAP
$74.60
Price history computed in-house
1W
+2.44%
1M
+3.07%
3M
+22.47%
1Y
+7.59%
YTD
-8.69%
SMA 50 $68.78 · above
SMA 200 $73.15 · above
52W position 63%
COO overview
Related filings and maps
Public disclosures
Congress activity in COO
Official filing ↗
COO · Transaction May 29, 2026 · Filed Jun 8, 2026 · $1,001 to $15,000
The Cooper Companies, Inc. - Common Stock · Transaction Mar 27, 2026 · Filed Jul 21, 2026 · $1,001 to $15,000
COO · Transaction Dec 10, 2025 · Filed Jan 12, 2026 · $1,001 to $15,000
Rob BresnahanSell
COO · Transaction May 15, 2025 · Filed Jun 9, 2025 · $1,001 to $15,000
Federal contracts
COO contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for COO in this window.
Lobbying spend
COO lobbying filings, year to date.
Registered lobbying filings matched to The Cooper Companies, Inc. Common Stock.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for COO in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for COO.
Options
Sovereign unlock shows live options positioning for COO.